Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Solomon

Showing results (591-600 of 1,173) with videos related to

Pageof 118
Sort By:
Gastroenterology|April 1, 1997
Rapid development of hepatic alpha1-antitrypsin globules after liver transplantation for chronic hepatitis CC Combs, E M Brunt, H Solomon, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|April 1, 1992
In vivo binding and autoradiographic imaging of (+)-3-[125I]Iodo-MK-801 to the NMDA receptor-channel complex in rat brainE G Gibson, H D Burns, H H Thorpe, et al.
Circulation|April 21, 2004
Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adultsDaniel H Solomon, Sebastian Schneeweiss, Robert J Glynn, et al.
Arthritis and Rheumatism|February 8, 2006
Prescription opioid use among older adults with arthritis or low back painDaniel H Solomon, Jerry Avorn, Philip S Wang, et al.
Epidemiology (Cambridge, Mass.)|January 26, 2016
Tumor Necrosis Factor-α Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid ArthritisRishi J Desai, Daniel H Solomon, Sebastian Schneeweiss, et al.
JAMA Internal Medicine|December 2, 2014
Statin therapy and risk of fracture: results from the JUPITER randomized clinical trialJessica M Peña, Sara Aspberg, Jean MacFadyen, et al.
Arthritis Research & Therapy|June 15, 2017
Drug safety analyses in a rheumatoid arthritis registry: application of different approaches regarding timing of exposure and confounder measurementDaniel H Solomon, Nancy A Shadick, Michael E Weinblatt, et al.
Annals of the Rheumatic Diseases|June 13, 2014
Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort studySeoyoung C Kim, Sebastian Schneeweiss, Robert J Glynn, et al.
Pharmacoepidemiology and Drug Safety|September 21, 2022
Examining the potential direct cardiovascular benefit of tumor-necrosis factor inhibitor in rheumatoid arthritis: Natural and controlled direct effect analysesKazuki Yoshida, Leslie R Harrold, Nicole Middaugh, et al.
ACR Open Rheumatology|April 11, 2022
Time-Varying Association of Rheumatoid Arthritis Disease Activity to Subsequent Cardiovascular RiskKazuki Yoshida, Leslie R Harrold, Nicole Middaugh, et al.
Pageof 118

Showing results (591-600 of 1,173) with videos related to

Sort By:
Pageof 118
Gastroenterology|April 1, 1997
Rapid development of hepatic alpha1-antitrypsin globules after liver transplantation for chronic hepatitis CC Combs, E M Brunt, H Solomon, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|April 1, 1992
In vivo binding and autoradiographic imaging of (+)-3-[125I]Iodo-MK-801 to the NMDA receptor-channel complex in rat brainE G Gibson, H D Burns, H H Thorpe, et al.
Circulation|April 21, 2004
Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adultsDaniel H Solomon, Sebastian Schneeweiss, Robert J Glynn, et al.
Arthritis and Rheumatism|February 8, 2006
Prescription opioid use among older adults with arthritis or low back painDaniel H Solomon, Jerry Avorn, Philip S Wang, et al.
Epidemiology (Cambridge, Mass.)|January 26, 2016
Tumor Necrosis Factor-α Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid ArthritisRishi J Desai, Daniel H Solomon, Sebastian Schneeweiss, et al.
JAMA Internal Medicine|December 2, 2014
Statin therapy and risk of fracture: results from the JUPITER randomized clinical trialJessica M Peña, Sara Aspberg, Jean MacFadyen, et al.
Arthritis Research & Therapy|June 15, 2017
Drug safety analyses in a rheumatoid arthritis registry: application of different approaches regarding timing of exposure and confounder measurementDaniel H Solomon, Nancy A Shadick, Michael E Weinblatt, et al.
Annals of the Rheumatic Diseases|June 13, 2014
Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort studySeoyoung C Kim, Sebastian Schneeweiss, Robert J Glynn, et al.
Pharmacoepidemiology and Drug Safety|September 21, 2022
Examining the potential direct cardiovascular benefit of tumor-necrosis factor inhibitor in rheumatoid arthritis: Natural and controlled direct effect analysesKazuki Yoshida, Leslie R Harrold, Nicole Middaugh, et al.
ACR Open Rheumatology|April 11, 2022
Time-Varying Association of Rheumatoid Arthritis Disease Activity to Subsequent Cardiovascular RiskKazuki Yoshida, Leslie R Harrold, Nicole Middaugh, et al.
Pageof 118